NVDA
NVIDIA Corporation
NVDA has the edge over OSPN overall, supported by stronger modeled upside and stronger valuation.
OSPN
OneSpan Inc.
OSPN's outlook is improving, though it still trails on the overall score.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
OSPN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
OSPN's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over OSPN in the historical PE scenario, which offers more potential upside but is not a forecast.
OSPN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.3x | $15.07 | -33% |
| Current | 12x | $22.43 | — |
| Forward | 17x | $22.43 | — |
| Fair | 23x | $40.90 | +82% |
| Expensive | 80x | $146 | +549% |
Historical ranges are pointers, not guarantees.
OSPN's PE is in its fair range at 12x. On analysts' estimates for next year's earnings, today's price would be 17x.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
OSPN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for OSPN, with profitability improving.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA's earnings per share have climbed steadily: $7.91 over the past year, up 125% from the year before, and higher year over year for 13 quarters in a row.
OSPN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.34 | -26% |
| Q3 2026 | $1.81 | +22% |
| Q2 2026 | $1.78 | +17% |
| Q1 2026 | $1.81 | +22% |
| Q4 2025 | $1.88 | +29% |
| Q3 2025 | $1.48 | +100% |
| Q2 2025 | $1.52 | +253% |
| Q1 2025 | $1.48 | +$1.66 |
| Q4 2024 | $1.46 | +$2.20 |
OSPN's earnings per share have climbed steadily: $1.81 over the past year, up 22% from the year before, and higher year over year for 11 quarters in a row.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over OSPN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over OSPN on profitability, with a higher operating margin.
OSPN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $63.9M | +12% |
| Q2 2026 | $60.5M | +1% |
| Q1 2026 | $65.9M | +4.1% |
| Q4 2025 | $62.9M | +2.9% |
| Q3 2025 | $57.1M | +1.4% |
| Q2 2025 | $59.8M | -1.8% |
| Q1 2025 | $63.4M | -2.3% |
| Q4 2024 | $61.2M | -2.8% |
OSPN's revenue has grown year over year for five quarters in a row: $64M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +0.1 points |
| Q2 2026 | 14% | -3.1 points |
| Q1 2026 | 22% | -4.7 points |
| Q4 2025 | 20% | +0.6 points |
| Q3 2025 | 14% | -5.6 points |
| Q2 2025 | 18% | +5 points |
| Q1 2025 | 27% | +5.4 points |
| Q4 2024 | 19% | +16 points |
OSPN's operating margin was 14% last quarter, about level with the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over OSPN on cash flow, with more consistent year-over-year improvement.
OSPN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13.3M | +51% |
| Q2 2026 | -$3.3M | -175% |
| Q1 2026 | $25.1M | -9.7% |
| Q4 2025 | $9.6M | -7.9% |
| Q3 2025 | $8.8M | -27% |
| Q2 2025 | $4.4M | +16669% |
| Q1 2025 | $27.7M | +16% |
| Q4 2024 | $10.5M | +$10.8M |
OSPN generated $45M in free cash flow over the past year, down 13% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over OSPN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
OSPN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.4% | +897K shares |
| 1 year | +0.7% | +271K shares |
| 3 years | -3.5% | -1.4M shares |
| 5 years | -2.5% | -989K shares |
OSPN has 39M diluted shares, up 0.7% from a year ago, despite $15M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2.9M |
| Q1 2026 | $5.4M |
| Q4 2025 | $6.8M |
| Q4 2024 | $3,000 |
| Q4 2023 | $25.6M |
| Q3 2023 | $3.5M |
| Q4 2022 | — |
OSPN spent $15M buying back its own shares over the past year.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
OSPN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.2x | Net Cash |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -1.9x | Net Cash |
| Q4 2024 | -1.6x | Net Cash |
OSPN has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
OSPN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.7 | Neutral |
| Stochastic | 65.9 | Neutral |
OSPN's weekly RSI is 67 (neutral) and its Stochastic is 66 (neutral).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
OSPN PE vs Technology Sector
| Metric | OSPN | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 28x | 56% below |
| PE % | 48 | 35 | 13 pts above |
OSPN has the edge over NVDA on valuation relative to its sector.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
OSPN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.2 | 11% above |
| 20 week MA | $17.7 | 27% above |
| 50 week MA | $14.3 | 57% above |
| 100 week MA | $15.1 | 49% above |
| 200 week MA | $14.2 | 58% above |
OSPN has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
OSPN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.2 | $21.3 | +24% |
| 2021 | $21.3 | $16.9 | -21% |
| 2022 | $16.9 | $11.5 | -32% |
| 2023 | $11.5 | $10.7 | -7% |
| 2024 | $10.7 | $18.8 | +75% |
| 2025 | $18.8 | $12.9 | -31% |
| 2026 YTD | $12.9 | $22.4 | +74% |
OSPN has the edge over NVDA on returns for 2026, with the stronger performance.